Pitcairn’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Sell |
9,501
-1,089
| -10% | -$132K | 0.08% | 232 |
|
2025
Q1 | $1.18M | Buy |
10,590
+429
| +4% | +$47.8K | 0.07% | 239 |
|
2024
Q4 | $989K | Buy |
10,161
+866
| +9% | +$84.3K | 0.06% | 266 |
|
2024
Q3 | $1.07M | Sell |
9,295
-703
| -7% | -$80.9K | 0.06% | 261 |
|
2024
Q2 | $1.06M | Buy |
9,998
+890
| +10% | +$94.7K | 0.07% | 257 |
|
2024
Q1 | $881K | Buy |
9,108
+454
| +5% | +$43.9K | 0.06% | 284 |
|
2023
Q4 | $874K | Buy |
8,654
+3,960
| +84% | +$400K | 0.06% | 268 |
|
2023
Q3 | $478K | Buy |
4,694
+219
| +5% | +$22.3K | 0.04% | 372 |
|
2023
Q2 | $452K | Buy |
4,475
+698
| +18% | +$70.4K | 0.04% | 383 |
|
2023
Q1 | $347K | Buy |
3,777
+1,001
| +36% | +$92.1K | 0.03% | 454 |
|
2022
Q4 | $252K | Sell |
2,776
-348
| -11% | -$31.6K | 0.03% | 507 |
|
2022
Q3 | $237K | Buy |
3,124
+272
| +10% | +$20.6K | 0.03% | 503 |
|
2022
Q2 | $241K | Buy |
+2,852
| New | +$241K | 0.03% | 504 |
|
2016
Q2 | – | Sell |
-11,128
| Closed | -$722K | – | 471 |
|
2016
Q1 | $722K | Sell |
11,128
-1,677
| -13% | -$109K | 0.09% | 183 |
|
2015
Q4 | $987K | Buy |
+12,805
| New | +$987K | 0.11% | 139 |
|